Societe Generale Private Banking:企業の戦略・SWOT・財務分析

◆英語タイトル:Societe Generale Private Banking - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5235
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:Financial Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Societe Generale Private Banking – Strategy, SWOT and Corporate Finance Report
Summary

Societe Generale Private Banking – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Societe Generale Private Banking (SGPB), private bank of Societe Generale Group, provides comprehensive wealth management and private banking services for high net-worth individuals, entrepreneurs, business owners, and people involved in liberal art and media. It also provides wealth management services to ultra-high net-worth individuals. The services include wealth planning, investment solutions, financing solutions, and diversification services. The bank operates through its offices in Belgium, Channel Islands, France, Gibraltar, Ireland, Luxembourg, Monaco, Switzerland, the UK, and Singapore. SGPB is headquartered in Paris, Ile de France, France.

Scope

- Detailed information on Societe Generale Private Banking required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Societe Generale Private Banking in the form of a SWOT analysis
- An in-depth view of the business model of Societe Generale Private Banking including a breakdown and examination of key business segments
- Intelligence on Societe Generale Private Banking’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Societe Generale Private Banking, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Societe Generale Private Banking and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Societe Generale Private Banking as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Societe Generale Private Banking’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Societe Generale Private Banking: Company Overview
Societe Generale Private Banking: Overview and Key Facts
Societe Generale Private Banking: Overview
Societe Generale Private Banking: Key Facts
Societe Generale Private Banking: Key Employees
Societe Generale Private Banking: Key Employee Biographies
Societe Generale Private Banking: Major Products and Services
Societe Generale Private Banking: Company History
Societe Generale Private Banking: Locations and Subsidiaries
Societe Generale Private Banking: Key Competitors
Societe Generale Private Banking: Company Analysis
Societe Generale Private Banking: Business Description
Societe Generale Private Banking: SWOT Analysis
Societe Generale Private Banking: SWOT Overview
Societe Generale Private Banking: Strengths
Societe Generale Private Banking: Weaknesses
Societe Generale Private Banking: Opportunities
Societe Generale Private Banking: Threats
Societe Generale Private Banking: Recent Developments
Societe Generale Private Banking: News and Events Summary
Societe Generale Private Banking: Business Expansion
Societe Generale Private Banking: Business Reorganization
Societe Generale Private Banking: Corporate Governance
Societe Generale Private Banking: Financial Deals
Societe Generale Private Banking: Financial Performance
Societe Generale Private Banking: IT Spending Announcements
Societe Generale Private Banking: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Societe Generale Private Banking: Key Facts
Table 2: Societe Generale Private Banking: Key Employees
Table 3: Societe Generale Private Banking: Company History
Table 4: Societe Generale Private Banking: Locations and Subsidiaries
Table 5: Societe Generale Private Banking: Key Competitors
Table 6: Societe Generale Private Banking: News and Events Summary
Table 7: Societe Generale Private Banking: Business Expansion
Table 8: Societe Generale Private Banking: Business Reorganization
Table 9: Societe Generale Private Banking: Corporate Governance
Table 10: Societe Generale Private Banking: Financial Deals
Table 11: Societe Generale Private Banking: Financial Performance
Table 12: Societe Generale Private Banking: IT Spending Announcements
Table 13: Societe Generale Private Banking: Strategy and Operations

★海外企業調査レポート[Societe Generale Private Banking:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fortitech Inc.:戦略・SWOT・企業財務分析
    Fortitech Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortitech Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Teva Pharmaceutical Industries Limited:企業の戦略・SWOT・財務情報
    Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Teva Pharmaceutical Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • PDS Biotechnology Corp-製薬・医療分野:企業M&A・提携分析
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops immunotherapies and vaccines for cancer and infectious disease. The company uses versamune technology, which is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothe …
  • NorthWestern Corporation:発電所・企業SWOT分析
    NorthWestern Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Boral Limited:企業の戦略・SWOT・財務情報
    Boral Limited - Strategy, SWOT and Corporate Finance Report Summary Boral Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Pluristem Therapeutics Inc (PSTI):企業の財務・戦略的SWOT分析
    Summary Pluristem Therapeutics Inc (Pluristem) operates as a clinical-stage biotherapy company that focuses on the development of placental-derived cell therapies. Its PLacental eXpanded (PLX) cells are adherent stromal cells that can be administered to patients without tissue or genetic matching. T …
  • Nestle SA:企業のM&A・事業提携・投資動向
    Nestle SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Nestle SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Leidos Holdings Inc:企業の戦略・SWOT・財務情報
    Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Leidos Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Edinburgh Molecular Imaging Ltd:企業の製品パイプライン分析2018
    Summary Edinburgh Molecular Imaging Ltd (EM Imaging) is a biotechnology company that develops optical molecular imaging technology. The company offers discovery and development of small molecules and peptides. It designs agents to improve the diagnosis and treatment of cancer and lung diseases. EM I …
  • Sillajen Biotherapeutics (215600):製薬・医療:M&Aディール及び事業提携情報
    Summary Sillajen Biotherapeutics (SillaJen), formerly SillaJen Inc, is a biotechnology company that designs and develops oncolytic immunotherapeutics for the treatment of cancer. The company’s pipeline products comprise Pexa-Vec, an oncolytic immunotherapeutic virus which is in Phase III trial that …
  • Oiltanking GmbH:企業の戦略的SWOT分析
    Oiltanking GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Atopix Therapeutics Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Baltimore Gas and Electric Company:電力:M&Aディール及び事業提携情報
    Summary Baltimore Gas and Electric Company (BGE), a subsidiary of Exelon Corporation, is a regulated public utility that purchases, transmits, distributes and sells electricity; and purchases, sells and distributes natural gas. The company also offers services such as billing, emergency response, me …
  • Pfizer Inc.:企業の戦略・SWOT・財務情報
    Pfizer Inc. - Strategy, SWOT and Corporate Finance Report Summary Pfizer Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Yanlord Land Group Ltd
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Entergy Corporation:企業の戦略・SWOT・財務情報
    Entergy Corporation - Strategy, SWOT and Corporate Finance Report Summary Entergy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Stemline Therapeutics Inc (STML):製薬・医療:M&Aディール及び事業提携情報
    Summary Stemline Therapeutics Inc (Stemline) is a clinical stage biopharmaceutical company that develops therapeutics to treat cancer stem cells and tumor bulk. The company has developed discovery platform StemScreen to identify novel compounds that target and kill cancer stem cells. Its products pi …
  • AECI Ltd (AFE):企業の財務・戦略的SWOT分析
    AECI Ltd (AFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Immunomedics Inc (IMMU)-医療機器分野:企業M&A・提携分析
    Summary Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and automimmune disorders. The company’s portfolio of antibody-drug conjugates are aimed to sp …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆